Portfolio
Our portfolio management advances successful programs (developed via Venture Builder, LAB 150 and UTEST) into company creation. We help nascent companies access talent for board and leadership roles, and our network of strategic partners is leveraged for business development engagement.
Seed financing is available at this stage, through TIAP and its network of domestic and international funding partners (VC and industry).
PORTFOLIO COMPANIES
- All
- Exited

Radiant Biotherapeutics
Leveraging multi-specific/valent antibody platform to develop therapeutics in cancer, inflammation and infectious disease

Damona Pharmaceuticals
Development of small molecules for treatment of cognitive symptoms associated with brain disorders and aging

BlueDot
Global biothreat Intelligence platform to monitor infectious disease transmission and outbreak

Fibrocor Therapeutics
Developing fibrosis therapeutics with a patient derived target discovery engine

Bright Angel Therapeutics
Development of novel therapeutics for treatment of drug-resistant and life-threatening fungal infections

PhenoTips (Gene42)
Clinical software for collection of phenotpic patient information with genetic disorders

Quantum Bridge Technologies
Quantum internet that changes that secures development and transfer of data